We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$591B
AUM Growth
-$94.6B
Cap. Flow
+$3.09B
Cap. Flow %
0.52%
Top 10 Hldgs %
20.46%
Holding
2,656
New
75
Increased
1,551
Reduced
819
Closed
97

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.72B
2
BKNG icon
Booking.com
BKNG
+$2.61B
3
RHT
Red Hat Inc
RHT
+$1.62B
4
JPM icon
JPMorgan Chase
JPM
+$1.43B
5
STT icon
State Street
STT
+$1.29B

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 17.53%
3 Financials 14.18%
4 Consumer Discretionary 14.02%
5 Communication Services 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BID
1176
DELISTED
Sotheby's
BID
$17.9M ﹤0.01%
451,531
-3,705
-0.8% -$151K
STX icon
1177
Seagate
STX
$209B
$17.9M ﹤0.01%
464,518
+340
+0.1% +$14.3K
GGAL icon
1178
Galicia Financial Group
GGAL
$7.23B
$17.9M ﹤0.01%
647,626
-360,740
-36% -$9.16M
JRVR icon
1179
James River Group Holdings
JRVR
$199M
$17.9M ﹤0.01%
488,629
+1,856
+0.4% +$70.7K
SFST icon
1180
Southern First Bancshares
SFST
$607M
$17.8M ﹤0.01%
556,303
-6,078
-1% -$218K
GSAH.U
1181
DELISTED
GS Acquisition Holdings Corp. Units, each consisting of one share of Class A common stock and one-th
GSAH.U
$17.8M ﹤0.01%
1,735,955
+1,391
+0.1% +$14.4K
IPG
1182
DELISTED
Interpublic Group of Companies
IPG
$17.8M ﹤0.01%
862,371
+9,437
+1% +$216K
CCRN
1183
DELISTED
Cross Country Healthcare
CCRN
$17.8M ﹤0.01%
2,424,831
+13,959
+0.6% +$117K
HAS icon
1184
Hasbro
HAS
$13.4B
$17.8M ﹤0.01%
218,754
+17,724
+9% +$1.65M
TTI icon
1185
TETRA Technologies
TTI
$1.29B
$17.6M ﹤0.01%
10,501,853
-173,459
-2% -$482K
CRSP icon
1186
CRISPR Therapeutics
CRSP
$5.22B
$17.6M ﹤0.01%
615,848
+413,212
+204% +$14.4M
DOV icon
1187
Dover
DOV
$28B
$17.6M ﹤0.01%
247,520
+16,000
+7% +$1.31M
PVH icon
1188
PVH
PVH
$3.76B
$17.5M ﹤0.01%
187,906
-1,890
-1% -$216K
VAR
1189
DELISTED
Varian Medical Systems, Inc.
VAR
$17.4M ﹤0.01%
153,575
-11,000
-7% -$1.26M
WRK
1190
DELISTED
WestRock Company
WRK
$17.2M ﹤0.01%
455,547
-36,795
-7% -$1.62M
MEI icon
1191
Methode Electronics
MEI
$602M
$17.2M ﹤0.01%
738,096
-465,618
-39% -$13.1M
ASIX icon
1192
AdvanSix
ASIX
$427M
$17.2M ﹤0.01%
704,807
-7,234
-1% -$201K
MOS icon
1193
The Mosaic Company
MOS
$6.92B
$17.1M ﹤0.01%
584,989
+29,814
+5% +$981K
HONE
1194
DELISTED
HarborOne Bancorp
HONE
$16.7M ﹤0.01%
1,891,221
+6,505
+0.3% +$63.8K
AES icon
1195
AES
AES
$10.5B
$16.7M ﹤0.01%
1,154,496
+33,400
+3% +$502K
ABEV icon
1196
Ambev
ABEV
$43.5B
$16.7M ﹤0.01%
4,247,800
+405,800
+11% +$1.73M
FFIV icon
1197
F5
FFIV
$24B
$16.6M ﹤0.01%
102,267
+610
+0.6% +$105K
AUTL
1198
Autolus Therapeutics
AUTL
$591M
$16.5M ﹤0.01%
501,540
-1,221
-0.2% -$40.2K
DEO icon
1199
Diageo
DEO
$52.8B
$16.5M ﹤0.01%
116,116
+1,622
+1% +$228K
CPS icon
1200
Cooper-Standard Automotive
CPS
$484M
$16.4M ﹤0.01%
264,179
-1,864
-0.7% -$150K

Similar funds

T. Rowe Price Associates's Q4 2018 Portfolio in Review

As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
  • T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
  • T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
  • T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
  • T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
  • T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.